AAA
DRNA

Affinity Asset Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Affinity Asset Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,000
Closed -$881K – 84
2020
Q4 		$881K Buy
+40,000
New +$881K 0.47% 39